Ohcanbohtosat - Santos Carvajal‐Gonzalez
- Čájehuvvo 1 - 5 / 5
-
1
Pharmacokinetics and pharmacodynamics of PF‐05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects Dahkki William S. Denney, Gabriele E. Sonnenberg, Santos Carvajal‐Gonzalez, Theresa Tuthill, V. Margaret Jackson
Almmustuhtton 2016Artigo -
2
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver‐Targeting Acetyl‐CoA Carboxylase Inhibitor (PF‐05221304): A Three‐Part Randomized Phase 1 Study Dahkki Arthur Bergman, Santos Carvajal‐Gonzalez, Sanela Tarabar, Aditi R. Saxena, William P. Esler, Neeta B. Amin
Almmustuhtton 2020Artigo -
3
Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis Dahkki Neeta B. Amin, Santos Carvajal‐Gonzalez, Julie J. Purkal, Tong Zhu, Collin Crowley, Sylvie Perez, Kristin Chidsey, Albert M. Kim, Bryan Goodwin
Almmustuhtton 2019Artigo -
4
Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems Dahkki Trenton T. Ross, Collin Crowley, Kenneth L. Kelly, Anthony Rinaldi, David A. Beebe, Matthew P. Lech, Robert V. Martinez, Santos Carvajal‐Gonzalez, Magalie Boucher, Dinesh Hirenallur‐Shanthappa, Jeffrey Morin, Alan Opsahl, Sarah Regina Vargas, Kendra K. Bence, Jeffrey A. Pfefferkorn, William P. Esler
Almmustuhtton 2020Artigo -
5
Decreasing the Rate of Metabolic Ketone Reduction in the Discovery of a Clinical Acetyl-CoA Carboxylase Inhibitor for the Treatment of Diabetes Dahkki David A. Griffith, Daniel W. Kung, William P. Esler, Paul A. Amor, Scott W. Bagley, Carine Beysen, Santos Carvajal‐Gonzalez, Shawn D. Doran, Chris Limberakis, Alan M. Mathiowetz, Kirk McPherson, David A. Price, Éric Ravussin, Gabriele E. Sonnenberg, James A. Southers, Laurel J. Sweet, Scott Turner, F.F. Vajdos
Almmustuhtton 2014Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Medicine
Chemistry
Internal medicine
Biochemistry
Biology
Enzyme
Insulin
Pharmacology
Acetyl-CoA carboxylase
Adverse effect
Beta oxidation
Disease
Endocrinology
Fatty liver
Lipogenesis
Metabolism
Nonalcoholic fatty liver disease
Pharmacodynamics
Pharmacokinetics
Postprandial
Pyruvate carboxylase
Steatohepatitis
Steatosis
Tolerability
Agonist
Alternative medicine
Biotechnology
Diacylglycerol kinase
Fibrosis
Gastric emptying